New multicomponent crystals of climbazole (CLB) with fumaric acid (FumAc) and tioconazole (TCL) with oxalic (OxlAc), malonic (MlnAc), fumaric, and DL-tartaric (TartAc) acids were obtained by liquid-assisted grinding. The single crystals of CLB were obtained for the first time, and the crystal structure was characterized. The crystal structures of the four multicomponent crystals studied[CLB + FumAc] cocrystal (2:1), [TCL + MlnAc] salt (1:1), [TCL + FumAc] salt (1:1), and [TCL + TartAc + H 2 O] salt (1:1:1)the single crystals of which were obtained by slow evaporation form solution were determined. The influence of the coformer structure of the multicomponent crystals on CLB and TCL conformational flexibility was discussed. A thermal analysis of the studied multicomponent crystals was carried out. The [TCL + TartAc + H 2 O] salt (1:1:1) dehydration mechanism was analyzed by differential scanning calorimetry, a thermogravimetric method, and thermomicroscopy. It was established that the completion of the [TCL + TartAc + H 2 O] salt (1:1:1) dehydration process was followed by melting of the eutectic mixture and crystallization of the [TCL + TartAc] salt (1:1). A study of the multicomponent crystal solubility was carried out in a phosphate buffer solution at pH 6.8. Cocrystallization/salt formation of the studied active pharmaceutical ingredients with dicarboxylic acids not only significantly improved their solubility but also maintained the level of supersaturation in the solution for quite a long time.